Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation

Stem Cell Research

Volumn 13, Issue 3, 2014, Pages 532-541

  Senyo, Samuel E ^a,b,c,d   Lee, Richard T ^a,b,c,d   Kühn, Bernhard ^c,d,e,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Brigham Regenerative Medicine Center   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d Harvard University   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC STEM CELL; CELL ACTIVATION; CELL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL METABOLISM; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CYTOKINESIS; DNA SYNTHESIS; DOWN REGULATION; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART REGENERATION; HOMEOSTASIS; HUMAN; MAMMAL; MITOSIS; NONHUMAN; POSTNATAL DEVELOPMENT; REGENERATION; REVIEW; TISSUE REGENERATION; TURNOVER TIME; UPREGULATION; ANIMAL; CYTOLOGY; HEART; PHYSIOLOGY; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; HEART; HUMANS; MYOCYTES, CARDIAC; REGENERATION; STEM CELLS;

EID: 84911417634     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.09.003     Document Type: Review

References (106)

1. Adler C.P., Costabel U. Cell number in human heart in atrophy, hypertrophy, and under the influence of cytostatics. Recent Adv. Stud. Cardiac Struct. Metab. 1975, 6:343.
2. Agah R., et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J. Clin. Invest. 1997, 100:2722. (Dec 1).
3. Ali S.R., et al. Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:8850. (Jun 17).
4. Andersen D.C., Ganesalingam S., Jensen C.H., Sheikh S.P. Do neonatal mouse hearts regenerate following heart apex resection?. Stem Cell Rep. 2014, 2:406. (Apr 8).
5. Beltrami A.P., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 2001, 344:1750. (Jun 7).
6. Bergmann O., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98. (Apr 3).
7. Bersell K., Arab S., Haring B., Kuhn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138:257. (Jul 23).
8. Bersell K., et al. Moderate and high amounts of tamoxifen in alphaMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis. Model. Mech. 2013, 6:1459. (Nov).
9. Bettencourt-Dias M., Mittnacht S., Brockes J.P. Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes. J. Cell Sci. 2003, 116:4001. (Oct 1).
10. Bicknell K.A., Coxon C.H., Brooks G. Forced expression of the cyclin B1-CDC2 complex induces proliferation in adult rat cardiomyocytes. Biochem. J. 2004, 382:411. (Sep 1).
11. Borisov A.B., Claycomb W.C. Proliferative potential and differentiated characteristics of cultured cardiac muscle cells expressing the SV40 T oncogene. Ann. N. Y. Acad. Sci. 1995, 752:80. (Mar 27).
12. Brooks G., Poolman R.A., Li J.M. Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors. Cardiovasc. Res. 1998, 39:301. (Aug).
13. Buckingham M.E., Meilhac S.M. Tracing cells for tracking cell lineage and clonal behavior. Dev. Cell 2011, 21:394. (Sep 13).
14. Chakraborty S., Sengupta A., Yutzey K.E. Tbx20 promotes cardiomyocyte proliferation and persistence of fetal characteristics in adult mouse hearts. J. Mol. Cell. Cardiol. 2013, 62:203. (Sep).
15. Chaudhry H.W., et al. Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J. Biol. Chem. 2004, 279:35858. (Aug 20).
16. Chen Z., Chua C.C., Ho Y.S., Hamdy R.C., Chua B.H. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2313. (May).
17. Chong J.J., et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510(7504):273-277. (Apr 30).
18. Claycomb W.C. Long-term culture and characterization of the adult ventricular and atrial cardiac muscle cell. Basic Res. Cardiol. 1985, 80(Suppl. 2):171.
19. Di Stefano V., Giacca M., Capogrossi M.C., Crescenzi M., Martelli F. Knockdown of cyclin-dependent kinase inhibitors induces cardiomyocyte re-entry in the cell cycle. J. Biol. Chem. 2011, 286:8644. (Mar 11).
20. Dispersyn G.D., et al. Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. Eur. Heart J. 2002, 23:849. (Jun).
21. Drenckhahn J.D., et al. Compensatory growth of healthy cardiac cells in the presence of diseased cells restores tissue homeostasis during heart development. Dev. Cell 2008, 15:521. (Oct).
22. Ebelt H., et al. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo. Cardiovasc. Res. 2008, 80:219. (Nov 1).
23. Ellison G.M., et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013, 154:827. (Aug 15).
24. Elser J.A., Margulies K.B. Hybrid mathematical model of cardiomyocyte turnover in the adult human heart. PLoS One 2012, 7:e51683.
25. Engel F.B., et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005, 19:1175. (May 15).
26. Engel F.B., Hsieh P.C., Lee R.T., Keating M.T. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15546. (Oct 17).
27. Flink I.L., Oana S., Maitra N., Bahl J.J., Morkin E. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J. Mol. Cell. Cardiol. 1998, 30:563. (Mar).
28. Garbern J.C., Lee R.T. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 2013, 12:689. (Jun 6).
29. Hare J.M., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369. (Dec 12).
30. Hashimoto H., et al. Time-lapse imaging of cell cycle dynamics during development in living cardiomyocyte. J. Mol. Cell. Cardiol. 2014, 72C:241. (Apr 3).
31. Haubner B.J., et al. Complete cardiac regeneration in a mouse model of myocardial infarction. Aging (Albany NY) 2012, 4(966). (Dec).
32. Heallen T., et al. Hippo signaling impedes adult heart regeneration. Development 2013, 140:4683. (Dec).
33. Hesse M., et al. Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle. Nat. Commun. 2012, 3:1076.
34. Hsieh P.C., et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 2007, 13:970.
35. Ibrahim M., Terracciano C., Yacoub M.H. Can bridge to recovery help to reveal the secrets of the failing heart?. Curr. Cardiol. Rep. 2012, 14:392. (Aug).
36. Ieda M., et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev. Cell 2009, 16:233. (Feb).
37. Ikenishi A., et al. Cell cycle regulation in mouse heart during embryonic and postnatal stages. Dev. Growth Differ. 2012, 54:731. (Oct).
38. Jopling C., et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 2010, 464:606. (Mar 25).
39. Katz E.B., et al. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am. J. Physiol. 1992, 262:H1867. (Jun).
40. Kerkela R., et al. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J. Clin. Invest. 2008, 118:3609. (Nov).
41. Kikuchi K., et al. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 2010, 464:601. (Mar 25).
42. Koitabashi N., et al. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ. Res. 2009, 105:12. (Jul 2).
43. Kubin T., et al. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell 2011, 9:420. (Nov 4).
44. Kuhn B., et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 2007, 13:962. (Aug).
45. Ladage D., et al. Stimulating myocardial regeneration with periostin peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis. PLoS One 2013, 8:e59656.
46. Lesauskaite V., Epistolato M.C., Ivanoviene L., Tanganelli P. Apoptosis of cardiomyocytes in explanted and transplanted hearts. Comparison of results from in situ TUNEL, ISEL, and ISOL reactions. Am. J. Clin. Pathol. 2004, 121:108. (Jan).
47. Lexow J., Poggioli T., Sarathchandra P., Santini M.P., Rosenthal N. Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. Dis. Model. Mech. 2013, 6:1470. (Nov).
48. Li F., Wang X., Capasso J.M., Gerdes A.M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 1996, 28:1737. (Aug).
49. Li J.M., Poolman R.A., Brooks G. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am. J. Physiol. 1998, 275:H814. (Sep).
50. Liao H.S., et al. Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ. Res. 2001, 88:443. (Mar 2).
51. Linzbach A.J. The muscle fiber constant and the law of growth of the human ventricles. Virchows Arch. 1950, 318:575.
52. Linzbach A.J. Heart failure from the point of view of quantitative anatomy. Am. J. Cardiol. 1960, 5:370. (Mar).
53. Litvin J., et al. Periostin and periostin-like factor in the human heart: possible therapeutic targets. Cardiovasc. Pathol. 2006, 15:24. (Jan-Feb).
54. Liu Y., Kitsis R.N. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J. Cell Biol. 1996, 133:325. (Apr).
55. Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8:389. (Apr 8).
56. Lorts A., Schwanekamp J.A., Elrod J.W., Sargent M.A., Molkentin J.D. Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair. Circ. Res. 2009, 104:e1. (Jan 2).
57. MacLellan W.R., et al. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol. Cell. Biol. 2005, 25:2486. (Mar).
58. Mahmoud A.I., et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 2013, 497(7448):249-253. (Apr 17).
59. Malliaras K., et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol. Med. 2013, 5(2):191-209. (Dec 19).
60. Mollova M., et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(4):1446-1451. (Jan 9).
61. Muhlfeld C., Nyengaard J.R., Mayhew T.M. A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovasc. Pathol. 2010, 19:65. (Mar-Apr).
62. Naqvi N., et al. A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 2014, 157:795. (May 8).
63. Oberpriller J.O., Oberpriller J.C. Response of the adult newt ventricle to injury. J. Exp. Zool. 1974, 187:249. (Feb).
64. Pasumarthi K.B., Field L.J. Cardiomyocyte cell cycle regulation. Circ. Res. 2002, 90:1044. (May 31).
65. Pasumarthi K.B., Nakajima H., Nakajima H.O., Soonpaa M.H., Field L.J. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ. Res. 2005, 96:110. (Jan 7).
66. Polizzotti B.D., Arab S., Kuhn B. Intrapericardial delivery of gelfoam enables the targeted delivery of periostin peptide after myocardial infarction by inducing fibrin clot formation. PLoS One 2012, 7:e36788.
67. Poolman R.A., Brooks G. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy. J. Mol. Cell. Cardiol. 1998, 30:2121. (Oct).
68. Porrello E.R., et al. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331:1078. (Feb 25).
69. Porrello E.R., et al. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc. Natl. Acad. Sci. U. S. A. 2012, 110:187. (Jan 2).
70. Porrello E.R., et al. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:187. (Jan 2).
71. Poss K.D., Wilson L.G., Keating M.T. Heart regeneration in zebrafish. Science 2002, 298:2188. (Dec 13).
72. Puente B.N., et al. The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 2014, 157:565. (Apr 24).
73. Rios H., et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol. Cell. Biol. 2005, 25:11131. (Dec).
74. Rumyantsev P.P., Carlson B.M. Growth and hyperplasia of cardiac muscle cells. Soviet medical reviews. Supplement series. Cardiology 1991, 376. Harwood Academic Publishers, London, U.K. ; New York, N.Y., U.S.A.
75. Sadek H.A., et al. Multi-investigator letter on reproducibility of neonatal heart regeneration following apical resection. Stem Cell Rep. 2014, 3:1. (Jul 8).
76. Saraste A., Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 2000, 45:528. (Feb).
77. Sdek P., et al. Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J. Cell Biol. 2011, 194:407. (Aug 8).
78. Senyo S.E., et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493:433. (Jan 17).
79. Sharov V.G., et al. Abnormalities of cardiocytes in regions bordering fibrous scars of dogs with heart failure. Int. J. Cardiol. 1997, 60:273. (Aug 8).
80. Shimazaki M., et al. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 2008, 205:295. (Feb 18).
81. Sohal D.S., et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 2001, 89:20. (Jul 6).
82. Soonpaa M.H., Field L.J. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 1997, 272:H220.
83. Soonpaa M.H., Kim K.K., Pajak L., Franklin M., Field L.J. Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 1996, 271:H2183. (Nov).
84. Soonpaa M.H., et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J. Clin. Invest. 1997, 99:2644. (Jun 1).
85. Soonpaa M.H., Rubart M., Field L.J. Challenges measuring cardiomyocyte renewal. Biochim. Biophys. Acta 2012, 1833:799. (Apr).
86. Steinhauser M.L., Lechene C.P. Quantitative imaging of subcellular metabolism with stable isotopes and multi-isotope imaging mass spectrometry. Semin. Cell Dev. Biol. 2013, 24:661. (Aug-Sep).
87. Steinhauser M.L., et al. Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism. Nature 2012, 481:516. (Jan 26).
88. Tang Y., Nyengaard J.R., Andersen J.B., Baandrup U., Gundersen H.J. The application of stereological methods for estimating structural parameters in the human heart. Anat. Rec. (Hoboken) 2009, 292(1630). (Oct).
89. Tang H.L., et al. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol. Biol. Cell 2012, 23:2240. (Jun).
90. Traverse J.H., et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 2012, 308:2380. (Dec 12).
91. Tsang V., et al. Late donor cardiectomy after paediatric heterotopic cardiac transplantation. Lancet 2009, 374:387. (Aug 1).
92. Tseng A.S., Engel F.B., Keating M.T. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem. Biol. 2006, 13:957. (Sep).
93. van Berlo J.H., et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 2014, 509:337. (May 15).
94. von Gise A., et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2394. (Feb 14).
95. Vulapalli S.R., Chen Z., Chua B.H., Wang T., Liang C.S. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H688. (Aug).
96. Wadugu B., Kuhn B. The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H2139. (Jun 1).
97. Walsh S., Ponten A., Fleischmann B.K., Jovinge S. Cardiomyocyte cell cycle control and growth estimation in vivo-an analysis based on cardiomyocyte nuclei. Cardiovasc. Res. 2010, 86:365. (Jun 1).
98. Wencker D., et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 2003, 111:1497. (May).
99. Wills A.A., Holdway J.E., Major R.J., Poss K.D. Regulated addition of new myocardial and epicardial cells fosters homeostatic cardiac growth and maintenance in adult zebrafish. Development 2008, 135:183. (Jan).
100. Wilson A., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118. (Dec 12).
101. Woo Y.J., et al. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 2006, 114:I206. (Jul 4).
102. Xin M., et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 2011, 4:ra70.
103. Yurkova N., et al. The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ. Res. 2008, 102:472. (Feb 29).
104. Zak R. Cell proliferation during cardiac growth. Am. J. Cardiol. 1973, 31:211. (Feb).
105. Zaruba M.M., Soonpaa M., Reuter S., Field L.J. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation 2010, 121:1992. (May 11).
106. Zhang Y., et al. Dedifferentiation and proliferation of mammalian cardiomyocytes. PLoS One 2010, 5:e12559.